Related Experiment Video
Updated: Jun 14, 2026

Assessment of Waste-Derived Biochars on the Health and Biological Activity of Soil
Published on: October 10, 2025
Decision-makers' perspectives on the use of bioaccessibility for risk-based regulation of contaminated land
Agnieszka E Latawiec1, Peter Simmons1, Brian J Reid1
1University of East Anglia, School of Environmental Sciences, NR4 7TJ, Norwich, Norfolk, UK.
Abstract:
Information on contaminant bioaccessibility has been recognized by researchers, legislators and regulators as a decision-support tool for contaminated land assessment and has been subject to interest and discussion at both national and international levels. A sustainable, proportionate and risk-based approach to contaminated land management has been adopted by contaminated land regimes throughout the world. While this approach guides national and international priorities, its practical implementation in many countries, including the United Kingdom, is reliant upon local authorities. Here, we present an investigation into the views of local authorities in England and Wales regarding the practical application of bioaccessibility and constraints associated with its implementation. The research involved an online survey followed by semi-structured interviews with selected respondents. A majority of survey respondents (70%) perceived bioaccessibility to be a useful tool that facilitates contaminated land management. However, 76% of participants indicated a need for more information regarding bioaccessibility as well as emphasising a need for more research into polycyclic aromatic hydrocarbons. Lack of statutory guidance was indicated by 78% of respondents as the main factor hampering the use of bioaccessibility data in regulatory decision-making. Divergence of policy-maker and local regulator perceptions of bioaccessibility was also indicated by the respondents. This research brings the voice of front-line regulators for contaminated land into the on-going discussion between policy-makers and scientists on the uses of bioaccessibility. This study concludes by proposing action priorities both for the research community and for policy-makers, which are transferable to risk-based regimes elsewhere.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Drug Control Governance: Regulatory Bodies and Their Impact
Bioavailability Study Design: Single Versus Multiple Dose Studies
Sources of Food Contamination
